Saturday, September 30, 2023
Saturday, September 30, 2023

Contact: 561.316.3330

Woebot Health Names Matt Borowiecki Chief Financial Officer

Woebot Health today announced that it has appointed Matt Borowiecki as its Chief Financial Officer. A member of the senior management team, Borowiecki will lead the company’s financial operations and strategy, including management and financial reporting, budgeting and long-term financial planning, and will also manage its capital structure. He reports to Chief Executive Officer Michael Evers.

Matt Borowiecki has more than 20 years of global experience in finance, strategy and corporate development across healthcare, insurance and financial services, and has managed acquisitions, divestitures, joint ventures and debt and equity financings totaling more than $60 billion of value. Before joining Woebot Health, Borowiecki was the Chief Financial Officer at Biofourmis, a technology-enabled care delivery and digital therapeutics company. In that position, he led Biofourmis’ financial operations as it scaled revenue, customers and employees and surpassed unicorn status.

Before that, Borowiecki was the Head of Capital Transactions and Structuring at MassMutual Financial Group. His healthcare industry experience dates to 2011 when he joined Aetna as its Director of Corporate Development and Enterprise Strategic Planning. Previously Borowiecki held positions of increasing responsibility at leading investment banks Morgan Stanley, Lehman Brothers and UBS.

“Matt’s deep understanding of the healthcare industry and investment acumen will be instrumental as we mature our operations and move to the next level of our company’s growth,” said Evers. “His strategic experience is complemented by a deep compassion and commitment to helping people access the mental health care they need. We’re delighted he’s joined at this very pivotal moment.”

“The last few years have placed a spotlight on mental health, while the last few months have seen incredible advances in technologies that can play a role in changing the way we deliver care,” said Borowiecki. “We have the opportunity to really make a difference in patients’ lives, and that’s extremely motivating.”

Borowiecki holds a Master of Business Administration degree from the Tuck School of Business at Dartmouth and a Bachelor of Arts degree in Economics from Kenyon College. He is an avid traveler who has visited 47 countries and dependencies and 44 U.S. states.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

MORE EXECUTIVES

CorWave Appoints Magalie Durrèche as Chief Financial Officer

Magalie Durrèche will oversee the financial management and participate in the strategic planning and fundraising of CorWave, a company developing and manufacturing a blood pump based on breakthrough technology. She succeeds Zina Hamoumi, who served as Chief Financial Officer for five years before deciding to focus on other projects.

Veracyte Names Dr Phillip G Febbo Chief Scientific Officer and Chief Medical Officer

“Phil G Febbo is an exceptional leader with a strong track record of driving successful commercialization of molecular tests through evidence development, guideline inclusion and key opinion leader support,” said Mr. Stapley. “His experience and expertise will be critical to further enhancing our ability to serve our customers and, ultimately, to transforming cancer care for patients all over the world.”

GrayMatters Health Expands US Executive Team, Including Appointment of Dr Aron Tendler as Chief Medical Office

Dr Aaron Tendler is a board-certified psychiatrist based in Palm Beach, Florida, bringing over 20 years of experience as an industry leader researching novel treatments for mental health disorders.

Carthera Appoints Dr Oern Stuge as Chairman of Board of Directors

Dr Oern Stuge brings 30+ years expertise with a wealth of experience in product development and commercial launches to support Carthera’s future growth.

Cytomos Appoints a New Director as £4 Mill Investment Sets Path for Commercialisation of Groundbreaking Cell Analysis Technology

The biotech company’s appointment of industry leader Dr Sharon Brownlow as Non-Executive Director further enhances Cytomos’ senior management team and its unique value proposition to key industry markets.

By using this website you agree to accept Medical Device News Magazine Privacy Policy